Into
Research and Development
12:33 May 22, 2013 Into (AGI) – Washington, May 22 – Identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before the cells that produce insulin are destroyed. The discovery has broad implications because ‘the protein’ responsible for protecting the body against excessive immune responses and may be used to treat or even prevent immune system disorders such as multiple sclerosis or rheumatoid arthritis. The protein in question and ‘the CD52 and it’ was detected by a team of Australian researchers of the Walter and Eliza Hall Institute (WEHI).
The study ‘was published in the journal Nature Immunology and led by Len Harrison who explained: “The CD52 protein is a candidate to be in the future a therapeutic agent for the prevention and treatment of autoimmune diseases such as type 1 diabetes. immune suppression carried out by CD52 and ‘a previously unreleased mechanism that the body uses to regulate and protect against excessive or harmful immune responses. ” Will constitute a premise that ‘the basis for experiments on the use of the protein in the treatment, prevention and treatment of autoimmune diseases. The study demonstrated that the removal of cells that produce the CD52 leads to a rapid development of diabetes.
.
IntoThe study ‘was published in the journal Nature Immunology and led by Len Harrison who explained: “The CD52 protein is a candidate to be in the future a therapeutic agent for the prevention and treatment of autoimmune diseases such as type 1 diabetes. immune suppression carried out by CD52 and ‘a previously unreleased mechanism that the body uses to regulate and protect against excessive or harmful immune responses. ” Will constitute a premise that ‘the basis for experiments on the use of the protein in the treatment, prevention and treatment of autoimmune diseases. The study demonstrated that the removal of cells that produce the CD52 leads to a rapid development of diabetes.
.
Latest from “Research and Development”
PORTALS AGI
THE VOICE OF THE CONSUMER
No comments:
Post a Comment